Medication info
Empagliflozin/Metformin Hydrochloride Tablets 5/1000 mg

Empagliflozin/Metformin Hydrochloride Tablets 5/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Brownish yellow, biconvex, oval film-coated tablet
Packaging
10 tablets/box [(10 tablets/PTP X 1)], 60 tablets/box [(10 tablets/PTP X 6)], 30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202201379 · Approved 2022.04.04 · Insurance code 669908420

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Difficulty in blood sugar control
  • type 2 diabetes
  • cardiovascular diseases
View approved original text

This drug is a treatment that helps control blood sugar levels in adults with type 2 diabetes by using Empagliflozin and Metformin together. It is primarily administered to patients whose blood sugar is not sufficiently controlled with diet and exercise alone. Moreover, in patients with type 2 diabetes accompanied by cardiovascular disease, caution is necessary regarding the occurrence of cardiovascular events, so it should be used with information from professional clinical trials. This drug improves glycemic control and is effectively used in the treatment of type 2 diabetes.

How to take

Adult dose

The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This drug is a medication that helps control blood sugar and is used in diabetes treatment. Caution is needed when taking this medication as there may be rare side effects such as severe lactic acidosis. Lactic acidosis could accumulate excess lactic acid in the body, leading to dangerous conditions. Additionally, if taken with insulin or sulfonylurea drugs, hypoglycemia can occur, so blood sugar changes should be closely monitored. Patients with severely impaired kidney function or certain acute illnesses should not use this medication. For instance, cases of dehydration, severe infections, shock, acute myocardial infarction fall under this category. If surgery is planned, or if undergoing tests with iodine contrast agents, this medication should be discontinued for a certain period before and after the test, and should only be resumed after confirming normal kidney function. It is advisable for women who are pregnant or may become pregnant, and nursing mothers not to take this drug. During the use of this medication, kidney function and blood creatinine levels should be regularly monitored to check kidney status. Irregular eating habits or poor nutritional status, as well as vigorous exercise may increase the risk of hypoglycemia or lactic acidosis, therefore caution is necessary. This drug may cause gastrointestinal disturbances (diarrhea, vomiting, abdominal pain, etc.), urinary tract infections, genital infections, increased urination, hypoglycemia, decreased fluid volume, and other side effects. In particular, genital or urinary tract infections may occur frequently, so if symptoms arise, consult a doctor immediately. During the use of this drug, it is best to avoid alcohol consumption, as alcohol may increase the risk of lactic acidosis. Additionally, there may be interactions with other medications, so it is essential to inform a doctor or pharmacist if you are taking other medications. Elderly patients or those with reduced kidney function should adjust the dose of this drug and monitor kidney function more frequently. In case of overdose, serious side effects may occur, and immediate medical attention should be sought. This medication is not recommended for children and should be stored safely out of reach of children.

Storage

This drug may be sensitive to air or moisture, so it must be stored in a tightly closed container. It's best to keep the storage temperature between 1 to 30 degrees Celsius at room temperature to maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

Brownish yellow, biconvex, oval film-coated tablet

Package unit

10 tablets/box [(10 tablets/PTP X 1)], 60 tablets/box [(10 tablets/PTP X 6)], 30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.